EP1007555A4 - Tropoelastinderivate - Google Patents

Tropoelastinderivate

Info

Publication number
EP1007555A4
EP1007555A4 EP98933366A EP98933366A EP1007555A4 EP 1007555 A4 EP1007555 A4 EP 1007555A4 EP 98933366 A EP98933366 A EP 98933366A EP 98933366 A EP98933366 A EP 98933366A EP 1007555 A4 EP1007555 A4 EP 1007555A4
Authority
EP
European Patent Office
Prior art keywords
derivatives
variants
expression products
hybrid molecules
tropoelastine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP98933366A
Other languages
English (en)
French (fr)
Other versions
EP1007555B1 (de
EP1007555A1 (de
Inventor
Anthony Steven Weiss
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Sydney
Original Assignee
University of Sydney
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Sydney filed Critical University of Sydney
Priority to EP08010161A priority Critical patent/EP1978031A3/de
Publication of EP1007555A1 publication Critical patent/EP1007555A1/de
Publication of EP1007555A4 publication Critical patent/EP1007555A4/de
Application granted granted Critical
Publication of EP1007555B1 publication Critical patent/EP1007555B1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Cosmetics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Lubricants (AREA)
  • Materials For Medical Uses (AREA)
EP98933366A 1997-07-18 1998-07-17 Tropoelastinderivate Expired - Lifetime EP1007555B1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP08010161A EP1978031A3 (de) 1997-07-18 1998-07-17 Tropoelastin-Derivate

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPO8117A AUPO811797A0 (en) 1997-07-18 1997-07-18 Tropoelastin derivatives
AUPO811797 1997-07-18
PCT/AU1998/000564 WO1999003886A1 (en) 1997-07-18 1998-07-17 Tropoelastin derivatives

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP08010161A Division EP1978031A3 (de) 1997-07-18 1998-07-17 Tropoelastin-Derivate

Publications (3)

Publication Number Publication Date
EP1007555A1 EP1007555A1 (de) 2000-06-14
EP1007555A4 true EP1007555A4 (de) 2003-08-13
EP1007555B1 EP1007555B1 (de) 2008-08-27

Family

ID=3802406

Family Applications (2)

Application Number Title Priority Date Filing Date
EP98933366A Expired - Lifetime EP1007555B1 (de) 1997-07-18 1998-07-17 Tropoelastinderivate
EP08010161A Withdrawn EP1978031A3 (de) 1997-07-18 1998-07-17 Tropoelastin-Derivate

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP08010161A Withdrawn EP1978031A3 (de) 1997-07-18 1998-07-17 Tropoelastin-Derivate

Country Status (10)

Country Link
US (3) US7803577B2 (de)
EP (2) EP1007555B1 (de)
JP (1) JP2001510032A (de)
KR (1) KR100636948B1 (de)
AT (1) ATE406382T1 (de)
AU (1) AUPO811797A0 (de)
CA (1) CA2296841C (de)
DE (1) DE69839939D1 (de)
NZ (1) NZ502026A (de)
WO (1) WO1999003886A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO811797A0 (en) 1997-07-18 1997-08-14 University Of Sydney, The Tropoelastin derivatives
US7193043B1 (en) 1998-07-17 2007-03-20 Weiss Anthony S Tropoelastin derivatives
AUPP472398A0 (en) 1998-07-17 1998-08-13 University Of Sydney, The Protease susceptibility II
US6903244B1 (en) * 1999-02-26 2005-06-07 University Of Utah Research Foundation Mice which are +/− or −/− for the elastin gene as models for vascular disease
CA2626637A1 (en) * 2005-10-19 2007-04-26 Kenton W. Gregory Method of using and producing tropoelastin and tropoelastin biomaterials
EP2117620A4 (de) 2006-09-29 2010-12-01 Martin Kean Chong Ng Protoelastin-biomaterialien auf tropoelastin-basis
BRPI0718615B8 (pt) 2006-11-13 2021-06-22 Allergan Australia Pty Ltd processo para produzir um material elástico a partir de tropoelastina e material elástico
WO2010078620A1 (en) 2009-01-07 2010-07-15 Martin Kean Chong Ng Chemically and biologically modified medical devices
DK2405936T3 (da) 2009-03-10 2019-11-04 Allergan Pharmaceuticals Int Ltd Injicerbare biomaterialer
HUE060291T2 (hu) 2011-09-30 2023-02-28 Allergan Pharmaceuticals Int Ltd Rugalmas rost in vivo szintézise
US9688741B2 (en) 2012-10-23 2017-06-27 Elastagen Pty Ltd Elastic hydrogel
ES2860023T3 (es) 2012-12-10 2021-10-04 Allergan Pharmaceuticals Int Ltd Fabricación de constructos elásticos tridimensionales escalables
EP4316537A3 (de) 2013-08-13 2024-04-10 Allergan Pharmaceuticals International Limited Regenerierung von geschädigtem gewebe
WO2017035595A1 (en) 2015-09-01 2017-03-09 Elastagen Pty Ltd Formation of bone
FR3051191B1 (fr) * 2016-05-13 2020-03-06 Centre National De La Recherche Scientifique Polypeptide derive de la tropoelastine et materiau biocompatible le comprenant
US11180541B2 (en) 2017-09-28 2021-11-23 Geltor, Inc. Recombinant collagen and elastin molecules and uses thereof
US20190275087A1 (en) 2018-03-01 2019-09-12 Allergan Pharmaceuticals International Limited Expansion and differentiation of stem cells
TW202104254A (zh) * 2019-04-12 2021-02-01 美商格爾托公司 重組彈性蛋白及其生產
US20200345623A1 (en) 2019-05-03 2020-11-05 Allergan Pharmaceuticals International Limited Methods of scar prevention and/or treatment
ES3024564T3 (en) 2019-08-23 2025-06-04 Allergan Pharmaceuticals Int Ltd Tropoelastin for use in treatment of acne scarring
CN115605237A (zh) * 2019-12-18 2023-01-13 阿勒根制药国际有限公司（Ie） 杂化聚合物材料及其用途
AU2021211721A1 (en) 2020-01-24 2022-08-18 Geltor, Inc. Animal-free dietary collagen
EP4100073A1 (de) * 2020-02-06 2022-12-14 Allergan Pharmaceuticals International Limited Gewebezüchtungsgerüste
CN115768496A (zh) 2020-05-14 2023-03-07 阿勒根制药国际有限公司 包括与透明质酸交联的原弹性蛋白的组合物及其使用方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994014958A1 (en) * 1992-12-22 1994-07-07 The University Of Sydney Synthetic polynucleotides

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474851A (en) 1981-10-02 1984-10-02 The University Of Alabama In Birmingham Elastomeric composite material comprising a polypeptide
US5250516A (en) 1986-04-17 1993-10-05 Uab Research Foundation Bioelastomeric materials suitable for the protection of burn areas or the protection of wound repair sites from the occurrence of adhesions
JPH01235472A (ja) 1988-03-16 1989-09-20 Fujitsu Ltd ファクシミリ装置
NZ230375A (en) 1988-09-09 1991-07-26 Lubrizol Genetics Inc Synthetic gene encoding b. thuringiensis insecticidal protein
US5726040A (en) 1993-11-10 1998-03-10 Ensley; Burt D. Cosmetic compositions including tropoelastin isomorphs
US7001328B1 (en) 1994-11-15 2006-02-21 Kenton W. Gregory Method for using tropoelastin and for producing tropoelastin biomaterials
US6451326B2 (en) 1996-05-02 2002-09-17 Burt D. Ensley Cosmetic compositions
US6489446B1 (en) * 1996-08-07 2002-12-03 Hsc Research And Development Limited Partnership Self-aligning peptides modeled on human elastin and other fibrous proteins
AU728480B2 (en) 1996-08-07 2001-01-11 Hospital For Sick Children, The Self-aligning peptides derived from elastin and other fibrous proteins
AUPO811797A0 (en) * 1997-07-18 1997-08-14 University Of Sydney, The Tropoelastin derivatives
US7193043B1 (en) * 1998-07-17 2007-03-20 Weiss Anthony S Tropoelastin derivatives
US6808707B2 (en) 2000-02-04 2004-10-26 Matrix Design Wound healing compositions and methods using tropoelastin and lysyl oxidase
EP2117620A4 (de) * 2006-09-29 2010-12-01 Martin Kean Chong Ng Protoelastin-biomaterialien auf tropoelastin-basis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994014958A1 (en) * 1992-12-22 1994-07-07 The University Of Sydney Synthetic polynucleotides

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DEBRA BEDELL-HOGAN ET AL.: "Oxidation, cross-linking, and insolubilization of recombinant tropoelastin by purified Lysyl oxidase", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 268, no. 14, 15 May 1993 (1993-05-15), MD US, pages 10345 - 10350, XP002235105 *
MICHAEL J. FAZIO ET AL.: "Isolation and characterization of human elastin cDNAs, and age-associated variation in elastin gene expression in cultured skin fibroblasts", LABORATORY INVESTIGATION, vol. 58, no. 3, March 1988 (1988-03-01), pages 270 - 277, XP008015156 *
STEPHEN L. MARTIN ET AL.: "Total synthesis and expression in Escherichia coli of a gene encoding human tropoelastin", GENE, vol. 154, 1995, AMSTERDAM NL, pages 159 - 166, XP004042466 *
ZENA INDIK ET AL.: "Production of recombinant human tropoelastin: Characterization and demonstration of immunologic and chemotactic activity", ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, vol. 280, no. 1, July 1990 (1990-07-01), pages 80 - 86, XP000933577 *

Also Published As

Publication number Publication date
KR20010021999A (ko) 2001-03-15
EP1007555B1 (de) 2008-08-27
EP1007555A1 (de) 2000-06-14
CA2296841A1 (en) 1999-01-28
ATE406382T1 (de) 2008-09-15
US8710015B2 (en) 2014-04-29
DE69839939D1 (de) 2008-10-09
US20120130046A1 (en) 2012-05-24
NZ502026A (en) 2002-03-01
EP1978031A3 (de) 2008-10-22
JP2001510032A (ja) 2001-07-31
AUPO811797A0 (en) 1997-08-14
US20110021752A1 (en) 2011-01-27
US7803577B2 (en) 2010-09-28
EP1978031A2 (de) 2008-10-08
WO1999003886A1 (en) 1999-01-28
CA2296841C (en) 2012-02-21
KR100636948B1 (ko) 2006-10-19
US20080039397A1 (en) 2008-02-14

Similar Documents

Publication Publication Date Title
DE69839939D1 (de) Tropoelastinderivate
DK0960107T3 (da) 6-Thiosubstituerede paclitaxeler
ATE418547T1 (de) Zwischenprodukte zur herstellung von anti- thrombotischen 4h-cyclopenta-1,3-dioxol-derivaten
DK0909183T3 (da) DHA-konjugerede farmaceutisk midler
PE14199A1 (es) Agonistas de 5-ht1f
PL337758A1 (en) Derivatives of piperazine and their application as anti-inflammatory agents
PT823889E (pt) Derivados de 1,3-propanodiol como compostos bioactivos
ES2158115T3 (es) Derivados de histidina y homohistidina como inhibidores de la farnesiltransferasa de proteinas.
HN1996000017A (es) Isotiazolonas
PT1017659E (pt) Tetra-hidronaftalenos substituidos e compostos analogos
IT1302347B1 (it) Procedimento per la produzione diretta di perossido di idrogeno.
CR9879A (es) Moduladores de ccr5 (divisional de la solicitud n° 6392)
DE69709407D1 (de) Zytotoxischer aminozucker und verwandte zuckerderivate von indolopyrrolocarbazolen
ATE167670T1 (de) N-alkylthiopolyaminderivate als radioprotektive mittel
MX9601994A (es) Profarmacos de derivados de paclitaxel.
DE59909607D1 (de) Tan-1057 derivate
PT928183E (pt) Utilizacao de 1-hidroxilo-2-piridoneno para o tratamento da dermatite seborroica
DE69832880D1 (de) Frazzled nukleotidsequenzen, expressionsprodukte, zusammensetzungen und verwendungen
BR9807312A (pt) Derivados de (4-piperidinil)-1h-2-benzopirano úteis como agentes antipsicóticos
PT951471E (pt) Inibidores cicloalquilo de farnesiltransferase de proteinas
PT1011329E (pt) Paclitaxeis de 7-metiltio-oxometilo e 7-metiltiodioxometilo
BR9710992A (pt) Derivados anticovulsivos úteis no tratamento de psorìase
BR9803717A (pt) ácidos indol-2-carbocìlicos substituìdos como inibidores de glucosil transferase.
BR9911356A (pt) Sìntese de benzo[f]quinolinonas
IT1289852B1 (it) Prodotto cosmetico per il trattamento delle smagliature

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000204

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20030627

17Q First examination report despatched

Effective date: 20040209

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REF Corresponds to:

Ref document number: 69839939

Country of ref document: DE

Date of ref document: 20081009

Kind code of ref document: P

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080827

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20081208

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080827

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080827

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080827

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080827

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20090127

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20090528

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080827

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20081127

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20090731

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20090731

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20090731

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20090717

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20081128

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20090717

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080827

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 19

REG Reference to a national code

Ref country code: DE

Ref legal event code: R082

Ref document number: 69839939

Country of ref document: DE

Representative=s name: WEICKMANN & WEICKMANN PATENT- UND RECHTSANWAEL, DE

Ref country code: DE

Ref legal event code: R082

Ref document number: 69839939

Country of ref document: DE

Representative=s name: WEICKMANN & WEICKMANN PATENTANWAELTE - RECHTSA, DE

Ref country code: DE

Ref legal event code: R081

Ref document number: 69839939

Country of ref document: DE

Owner name: ELASTAGEN PTY LTD, EVELEIGH, AU

Free format text: FORMER OWNER: THE UNIVERSITY OF SYDNEY, SYDNEY, NEUSUEDWALES/NEW SOUTH WALES, AU

REG Reference to a national code

Ref country code: GB

Ref legal event code: 732E

Free format text: REGISTERED BETWEEN 20170518 AND 20170524

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20170724

Year of fee payment: 20

Ref country code: GB

Payment date: 20170719

Year of fee payment: 20

Ref country code: FR

Payment date: 20170724

Year of fee payment: 20

REG Reference to a national code

Ref country code: FR

Ref legal event code: TP

Owner name: ELASTAGEN PTY LTD, AU

Effective date: 20170929

REG Reference to a national code

Ref country code: DE

Ref legal event code: R071

Ref document number: 69839939

Country of ref document: DE

REG Reference to a national code

Ref country code: GB

Ref legal event code: PE20

Expiry date: 20180716

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20180716